Our detailed biochemical analysis revealed that, in advanced PD, dopaminergic markers are slightly more depleted in adP than in the avP (-98.9% vs. -95.8% of DA levels compared to controls, respectively). This evidence concerns the gene WDTC1 and Parkinson disease.